Showing posts with label Bacteria. Show all posts
Showing posts with label Bacteria. Show all posts

Daily Science Journal (Jan. 16, 2008) — Green tea may help protect against autoimmune disease, Medical College of Georgia researchers say.

Dr Stephen Hsu and colleagues found that green tea may help protect against autoimmune disease. (Credit: Image courtesy of Medical College of Georgia)

Researchers studied an animal model for type I diabetes and primary Sjogren’s Syndrome, which damages the glands that produce tears and saliva.

They found significantly less salivary gland damage in a group treated with green tea extract, suggesting a reduction of the Sjogren’s symptom commonly referred to as dry mouth. Dry mouth can also be caused by certain drugs, radiation and other diseases.

Approximately 30 percent of elderly Americans suffer from degrees of dry mouth, says Dr. Stephen Hsu, a researcher in the MCG School of Dentistry and lead investigator on the study. Only 5 percent of the elderly in China, where green tea is widely consumed, suffer from the problem.


“Since it is an autoimmune disease, Sjogren’s Syndrome causes the body to attack itself and produce extra antibodies that mistakenly target the salivary and lacrimal glands,” he says. There is no cure or prevention for Sjogren’s Syndrome.

Researchers studied the salivary glands of the water-consuming group and a green tea extract-consuming group to look for inflammation and the number of lymphocytes, a type of white blood cells that gather at sites of inflammation to fend off foreign cells.

The group treated with green tea had significantly fewer lymphocytes, Dr. Hsu says. Their blood also showed lower levels of autoantibodies, protein weapons produced when the immune system attacks itself, he says.

Researchers already know that one component of green tea – EGCG – helps suppress inflammation, according to Dr. Hsu. "So, we suspected that green tea would suppress the inflammatory response of this disease. Those treated with the green tea extract beginning at three weeks, showed significantly less damage to those glands over time.”

Researchers also suspect that the EGCG in green tea can turn on the body’s defense system against TNF-alpha – a group of proteins and molecules involved in systemic inflammation. TNF-alpha, which is produced by white blood cells, can reach out to target and kill cells.

“The salivary gland cells treated with EGCG had much fewer signs of cell death caused by TNF-alpha,” Dr. Hsu says. “We don’t yet know exactly how EGCG makes that happen. That will require further study. In some ways, this study gives us more questions than answers.”

These results, published in a recent issue of Autoimmunity, reinforced findings of a 2005 study showing a similar phenomenon in a Petrie dish, Dr. Hsu says. Further study could help determine green tea’s protective role in other autoimmune diseases, including lupus, psoriasis, scleroderma and rheumatoid arthritis, he says.

Adapted from materials provided by Medical College of Georgia.

--------------------------------------------------------------------------------

Add On Article :

Cup Of Green Tea To Keep The Bacteria Away

Beneficial effects of green tea have been known for millenia, particularly in Asian cultures. An ancient Chinese proverb says: "Better to be deprived of food for three days, than tea for one". A cup of green tea contains up to 200 mg of catechins, whose biological activity has been mainly attributed to its antioxidant activity. Efficiency of green tea extract in oral hygiene has been known for centuries and this gave researchers a clue that antibacterial activity might be involved.

Now researchers from the National institute of Chemistry in Ljubljana, Slovenia discovered that the main ingredients of green tea are able to perform other tricks. They found out that green tea catechins inhibit essential bacterial enzyme DNA gyrase, which is the target of several existing clinically used drugs. By the use of NMR spectroscopy, researchers from Slovenia have now pinpointed the ATP-binding site of DNA gyrase as target of EGCG, the most abundant catechin from the green tea extract. Up to now several compounds targeted against the ATP-binding site of bacteria gyrase have been known but couldn't be used as drugs due to their side effects on mammalian cells.

Lead researcher Roman Jerala, the head of the Laboratory of Biotechnology at NIC explains: "We can anticipate to avoid the problem of toxicity using the compounds based on the green tea catechins, which have centuries of established safety record in the human diet."

This finding may be used to develop even more potent antibacterial compounds. Results were recently published in the Journal of Medicinal Chemistry.

Adapted from materials provided by National Institute Of Chemistry, Slovenia.




Read the rest of this entry »

Daily Science Journal (Nov. 12, 2007) — Scientists from the Max Planck Institute for Infection Biology in Berlin discovered why lung, but not skin, anthrax infections are lethal. As reported in the newest issue of PloS Pathogen (November 2007) Neutrophils, a form of white blood cells, play a key role in anthrax infections.

A human neutrophil takes up Bacillus anthracis. (Image: MPI for Infection Biology)

They can kill Bacillus anthracis by producing a protein called alpha-defensin. This discovery might now pave the way towards the development of new therapiesfor the fatal lung form of anthrax.


Bacillus anthracis is the causative agent of anthrax. What makes Bacillus anthracis especially dangerous is that these bacteria can form spores. The spores are extremely resistant against environmental stress and can survive for years.Infection with Bacillus anthracis can take place either via the lung or through the skin. Interestingly, the lung form of anthrax is almost always fatal, whereas skin infections remain localized and are rarely lethal. In contrast to the lung form, the skin form of anthrax can be treated without problems and most patients recover. During the past few years, Bacillus anthracis has also been used as a weapon for bioterrorism. Anthrax spores were sent in envelopes and inhaled and resulted in the death of 5 people in the USA.

The findings of the lab of Arturo Zychlinsky now help clarifying why the skin form is harmless in contrast to the lung form. After a skin infection with Bacillus anthracis, neutrophils are recruited to the site of infection. Neutrophils are white blood cells that can identify and kill microbes. In the skin, neutrophils take up the spores, which germinate inside the neutrophil to a vegetative ("growing") bacterium. This vegetative bacterium is then attacked and killed within the neutrophil. The scientists succeeded in identifying the substance responsible for the killing of the bacteria. After fractionation of neutrophil components only one protein remained which is sufficient for killing Bacillus anthracis: alpha-defensin

This mechanism is not effective in the lung form of anthrax. Here, the number of neutrophils recruited to the site of infection is known to be low, and insufficient to kill bacteria. Thus, inhaled spores can germinate and spread through the organism. The scientists in Berlin now hope that their discovery will help to develop new drugs against the lung form of anthrax. There might be the possibility that the inhalation of alphadefensin might kill vegetative bacteria in the lung and prevent dissemination.

Adapted from materials provided by Max Planck Society.




Read the rest of this entry »

Daily Science Journal (Nov. 8, 2007) — Amid continuing concerns that anthrax might be used as a bioterrorism weapon, government researchers report development of a faster, more sensitive blood test for detecting the deadly toxins produced by the anthrax bacterium, Bacillus anthracis. The test produces results in only 4 hours and could save lives by allowing earlier detection of infection, they say.

Anthrax spores as photographed under an electron microscope. (Credit: Courtesy of Centers for Disease Control and Prevention)

Standard identification of anthrax (Bacillus anthracis) infection relies on a combination of time-consuming steps, including cell culture and gene amplification, which can take several days to provide a diagnosis and have limitations for detecting early stages of infection. Early diagnosis is critical for effective treatment of pulmonary or inhalation anthrax, the most deadly form.


John R. Barr and colleagues in a multi-center team effort used a form of mass spectrometry to detect the presence of 'lethal factor,' the key toxin produced by the anthrax bug, in the blood of monkeys with inhalation anthrax.

The method took only four hours to identify the toxin and detected it at very low levels, demonstrating its potential for early detection of infection, the researchers say. The new method also shows promise as a research tool for providing a better understanding of the anthrax infection cycle and for evaluating the effectiveness of different therapies and methods to fight infections.

The article "Detection and Quantification of Anthrax Lethal Factor in Serum by Mass Spectrometry" is scheduled for publication in the Nov. 22 issue of ACS' Analytical Chemistry.

Adapted from materials provided by American Chemical Society, via EurekAlert!, a service of AAAS.




Read the rest of this entry »

Daily Science Journal (Jul. 23, 2007) — Scientists have identified a chemical that could be used as a new drug against anthrax.

Anthrax is a deadly disease caused by spores that germinate into bacteria, which then release a deadly toxin. Spores that are inhaled by animals or people germinate in the lungs to form bacteria, which then spread throughout the body, releasing the toxin and triggering the disease. Since spore germination is needed to cause infection, preventing germination is a potentially efficient way to stop the infection.


Jurgen Brojatsch, Ernesto Abel-Santos, and colleagues identified seven chemicals that block the germination of cultured anthrax spores. They also showed that one of these compounds, 6-thioguanosine, blocked the spores' germination inside mammalian cells, thus blocking anthrax infection. The scientists are now planning to test 6-thioguanosine in mice infected with the anthrax bacterium. This compound is a known anticancer agent with well-studied pharmacological properties, which could help save time and money if it is used in clinical trials.

Article: "Identification of an in Vivo Inhibitor of Bacillus anthracis Spore Germination" by Monique Akoachere, Raynal C. Squires, Adel M. Nour, Ludmyl Angelov, Jurgen Brojatsch, and Ernesto Abel-Santos

Adapted from materials provided by American Society for Biochemistry and Molecular Biology, via EurekAlert!, a service of AAAS.




Read the rest of this entry »

Daily Science Journal (Jun. 15, 2007) — They are the largest group of white blood cells: neutrophil granulocytes kill microorganisms. Neutrophils catch microbes with extracellular structures nicknamed Neutrophil Extracellular Traps (NETs) that are composed of nucleic acid and aggressive enzymes.

Neutrophil granulocytes have trapped Shigella bacteria in NETs. (Image: Dr. Volker Brinkmann, Max Planck Institute for Infection Biology)

A group of scientists lead by Arturo Zychlinsky at the Max-Planck-Institute for Infectious Biology in Berlin, Germany discovered, how the neutrophils form this snaring network (Journal of Cell Biology, online, January 8, 2007). Once triggered, the cells undergo a novel program leading to their death. While they perish, the cells release the content of their nuclei. The nucleic acid, mingled with bactericidal enzymes, forms a lethal network outside the cell. Invading bacteria and pathogenic fungi get caught and killed in the NETs.


Every minute, several million neutrophils leave the bone marrow and are ready to defend the body of invading germs. They are the immune system’s first line of defence against harmful bacteria and migrate into the tissue at the site of infection to combat pathogens. For more than hundred years it was known that neutrophil granulocytes kill bacteria very efficiently by devouring them. After eating the germs neutrophils kill tehm with antimicrobial proteins.

The group of scientists lead by Arturo Zychlinsky at the Max-Planck-Institute for Infectious Biology discovered a second killing mechanism: neutrophil granulocytes can form web-like structures outside the cells composed of nucleic acid and enzymes which catch bacteria and kill them. The scientists were able to generate impressive micrographs of these nets. But it remained a mystery how the granulocytes could mobilise the contents of their nuclei and catapult it out of the cells.Only after lengthy live cell imaging and biochemical studies it became clear how neutrophils make NETs. The cells get activated by bacteria and modify the structure of their nuclei and granules, small enzyme deposits in the cytoplasm.

"The nuclear membrane disintegrates, the granules dissolve, and thus the NET components can mingle inside the cells", explains Volker Brinkmann, head of the microscopy group. At the end of this process, the cell contracts until the cell membrane bursts open and quickly releases the highly active melange. Once outside the cell, it unfolds and forms the NETs which then can trap bacteria.

Surprisingly, this process is as effective as devouring bacteria: "NETs formed by dying granulocytes kill as many bacteria as are eaten up by living blood cells", says Arturo Zychlinsky. Thus, neutrophils fulfil their role in the defence battle even after their deaths.

Adapted from materials provided by Max Planck Society.



Read the rest of this entry »